Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: ValuEngine, Inc.
$49.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In Class Action Lawsuit Against Abiomed Inc


Monday, 7 Jan 2013 09:45pm EST 

The Law Offices of Todd M. Garber announced that shareholders of Abiomed Inc have until January 15, 2013 to move for lead plaintiff status in the shareholder lawsuit filed in the United States District Court for the District of Massachusetts. The lawsuit was filed on behalf of a class (the Class) comprising all purchasers of Abiomed securities between August 5, 2011 and October 31, 2012, inclusive (the Class Period). The Complaint alleges that throughout the Class Period the defendants made materially false and misleading statements regarding the Company's business, operations and financial prospects. Specifically, defendants misrepresented and/or failed to disclose that: (1) the Company was improperly marketing and/or labeling its Impella 2.5 system; (2) Abiomed's financial results would be materially impacted if the Company were either forced to stop or discontinued its improper conduct; (3) the Company lacked adequate internal and financial controls; and (4) as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times. 

Company Quote

36.92
 --
17 Dec 2014